Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: In support of the South African National Comprehensive Care, Treatment and Management Programme for HIV and AIDS

Cytometry Part B - Clinical Cytometry

Volumn 74, Issue SUPPL. 1, 2008, Pages

  Glencross, Deborah K ^a,b   Janossy, George ^a   Coetzee, Lindi M ^b   Lawrie, Denise ^b   Aggett, Hazel M ^b   Scott, Lesley E ^a   Sanne, Ian ^a   McIntyre, James A ^a   Stevens, Wendy ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

Anti retroviral therapy (ART); CD4 lymphocyte count; CD45 antigen; External quality assessment; Flow cytometry; Health care quality assurance; Human immunodeficiency virus (HIV); Immunological monitoring; Internal quality control; PanLeucogated (PLG)

Indexed keywords

CD45 ANTIGEN; CD3 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; FLOW CYTOMETRY; HEALTH CARE QUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL; QUALITY CONTROL; SOUTH AFRICA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; HEALTH CARE; IMMUNOLOGY; METHODOLOGY; STANDARD; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD3; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COMPREHENSIVE HEALTH CARE; HUMANS; QUALITY ASSURANCE, HEALTH CARE; RESEARCH DESIGN; SOUTH AFRICA;

EID: 42449152330     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20384     Document Type: Article

References (44)

1. + T-cell enumeration by flow cytometry in HIV/AIDS. Clin Appl Immunol Rev 2003;4:91-107.
2. Glencross DK, Stevens W, Mendelow BV. Laboratory monitoring of HIV/AIDS in a resource poor setting. South Afr Med J 2003;93:262-263.
3. + T-cell enumeration. Cytometry 2002;50:69-77.
4. + T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. CDC and prevention. MMWR Recomm Rep 2003;52:1-13.
5. Mandy F, Bergeron M, Houle G, Bradley J, Fahey J. Impact of the international program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI. Cytometry 2002;50:111-116.
6. + T-lymphocyte enumeration: results from the last 9 years of the UK National External Quality Assessment Scheme for Immune Monitoring. Cytometry 2002;50:102-110.
7. World Health Organization emergency scale-up of antiretroviral therapy in resource-poor settings: Technical and operational recommendations to achieve 3 by 5. http://www.who.int/3by5/publications/documents/zambia/en/index.html (accessed September 2007)
8. + T lymphocytes in resource-limited settings: the ANRS 12-26 study. AIDS 2003;17:2201-2208.
9. + T-lymphocyte enumeration for implementation in developing countries. J Acquir Immune Defic Syndr 2001;26:193-195.
10. Teixeira PR, Vitoria MA, Barcarole J. Antiretroviral treatment in resource-poor settings: The Brazilian experience. J Acquir Immune Defic Syndr 2004;18 (Suppl 3):S5-S7.
11. + T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR Recomm Rep 1997;46:1-29.
12. Reimann KA, O'Gorman MR, Spritzler J, Wilkening CL, Sabath DE, Helm K, Campbell DE. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system.The NIAID DAIDS New Technologies Evaluation Group. Clin Diagn Lab Immunol 2000;7:344-351.
13. Schnizlein-Bick CT, Mandy F, O''Gorman MRG, Paxton H, Nicholson JKA, Hultin LE, Gelman R, Wilkening CL, Livnat D. Use of CD45 gating in three and four-color flow cytometric immunophenotyping: Guideline from the national institute of allergy and infectious diseases, division of AIDS. Cytometry B Clin Cytom 2002;50:46-52.
14. Clinical and Laboratory Standards Institute (CLSI, formerly the NCCLS).H42-A2. Enumeration of immunologically defined cell populations by flow cytometry. Wayne, PA, USA: Clinical and Laboratory Standards Institute. Approved guideline, 2nd ed. ISBN 1-56238-640-9, ISSN 0273-3099.
15. Scott LE, Glencross DK. Monitoring reproducibility of single analysis, single platform CD4 cell counts in a high volume, low resource laboratory setting using sequential bead count rates. Cytometry A 2005;67A:31-32.
16. Vercauteren G, Aggett HM, Mandy F and Glencross DK.Impact of the World Health Organisation Regional External Quality Assessment programme (AFREQAS) on the laboratory performance for CD4 enumeration for monitoring of ARV therapy in Resource limited settings. In: XVI International AIDS Conference 2006, Toronto, Canada. Abstract no. MOPE0138.
17. + stem cell counts by single-platform flow cytometry: the way forward. Br J Haematol 1999;106:1059-1062.
18. http://www.sanas.co.za (accessed September 2007).
19. http://www.PLGCD4.net (Accessed September 2007).
20. Bergeron M, Lustyik G, Phaneuf S, Ding T, Nicholson JK, Janossy G, Shapiro H, Barnett D, Mandy F. Stability of currently used cytometers facilitates the identification of pipetting errors and their volumetric operation: "time" can tell all. Cytometry 2003;52:37-39.
21. Storie I, Sawle A, Whitby L, Goodfellow K, Granger V, Reilly JT, Barnett D. Flow rate calibration II: a clinical evaluation study using Pan Leucogating as a single-platform protocol. Cytometry B Clin Cytom 2003;55:8-13.
22. + counting by a minimalist dual-platform flow cytometric method. J Biol Regul Homeost Agents 2003;17:358-365.
23. Pattanapanyasat K, Shain H, Noulsri E, Lerdwana S, Thepthai C, Prasertsilpa V, Likanonsakul S, Yothipitak P, Nookhai S, Eksaengsri A. A multi-center evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand. Cytometry A 2005;65A:29-36.
24. Pattanapanyasat K, Shain H, Prasertsilpa V, Noulsri E, Lerdwana S, Eksaengsri A. Low cost CD4 enumeration using generic monoclonal antibody reagents and a two-color user-defined MultiSETtrade mark protocol. Cytometry B 2006;70B:355-360.
25. Ceffa S, Erba F, Assane M, Coelho E, Calgaro M, Brando B. Panleucogating as an accurate and affordable flow cytometric protocol to analyse lymphocyte subsets among HIV+ patients on HAART treatment in Mozambique. J Biol Regul Homeost Agents 2005;19:169-175.
26. Glencross DK, Aggett HM, Stevens WS, Vercauteren G, Bergeron M, Houle G, Mandy F.XVI Improved between-laboratory performance of South African NHLS laboratories using PLG CD4 methodology for the National Antiretroviral treatment programme. In: XVI International AIDS Conference 2006, Toronto, Canada. Abstract no. MOPE0105.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
28. Denny T, Gelman R, Bergeron M, Forman M, Landay A, Louzao R, Mandy F, Schmitz J, Wilkening C, Glencross DK.A multi-lab study of CD4 counts using flow cytometric PanLeukogating (PLG): A NIAID-DAIDS immunology quality assessment program study. In: Conference for Retroviral and Opportunistic Infection (CROI), Boston, 2006. Abstract no. 670.
29. Stewart CC, Steinkamp JA. Quantitation of cell concentration using the flow cytometer. Cytometry 1982;2:238-243.
30. Glencross DK, Scott L, Stevens W, Stevens G, Mendelow BV. The challenge of laboratory monitoring of HIV. South Afr Med J 2002;92:248.
31. + T cell enumeration in HIV infection with limited resources. J Immunol Methods 1999;222:209-217.
32. +) T-cell counts on "single-platform" flow cytometers I. Primary CD4 gating. Br J Haematol 2000;111:1198-1208.
33. +)T-cell counting by flow cytometry: CD45 gating for volumetric analysis. Clin Diagn Lab Immunol 2002;9:1085-1094
34. Cassens U, Gohde W, Kuling G, Groning A, Schlenke P, Lehman LG, Traore Y, Servais J, Henin Y, Reichelt D, Greve B. Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodencient patients worldwide. Antivir Ther 2004;9:395-405.
35. + counts in HIV-infected patients in the USA and Uganda. J Acquir Immune Defic Syndr 2006;41:607-610.
36. Simson E, Groner W. Variability in absolute lymphocyte counts obtained by automated cell counters. Cytometry 1995;22:26-34.
37. Strauss K, Hannet I, Engels S, Shiba A, Ward DM, Ullery S, Jinguji MG, Valinsky J, Barnett D, Orfao A, Kestens L. Performance evaluation of the FACSCount System: A dedicated system for clinical cellular analysis. Cytometry 1996;26:52-59.
38. Gratama JW, Kraan J, Keeney M, Granger V, Barnett D. Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. Cytometry 2002;50:92-101.
39. Mandy FF, Bergeron M, Houle G, Azevedo L, Grangerrio A.Reliable CD4 T-cell enumeration in Brazil. The impact of single platform absolute counting technology with a linage specific marker and an external quality assessment program. In: XLV International AIDS Conference, 2004, Thailand. Abstract no. B12532.
40. Progress in scaling up access to HIV treatment in low and middle income countries.WHO/UNAIDS 2006, ISBN 92 4 159472 1. http://www.who.int/hiv/pub/ advocacy/universalaccess/en/ (accessed August 2007).
41. Glencross DK, Janossy G, Lawrie D, Coetzee L, Scott LE, Sanne I, McIntyre J, Stevens W. CD8/CD38 activation yields important clinical information of effective anti-retroviral therapy (ART): Findings from the first year of the CIPRA-SA cohort. Cytometry Part B: Clin Cytom 2008;74B (Suppl.): in press. doi: 10.1002/cyto.b.20391 (this issue).
42. + T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:332-340.
43. Jani IV, Janossy G, Brown DW, Mandy F. Multiplexed immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect Dis 2002;4:243-250.
44. + patients. Cytometry Part B Clin Cytom 2007;72B:22-33.